CBRE Group, Inc. (CBRE) stock
CBRENYSEReal EstateFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 11/3040% above fair value
$133.12+0.58 (+0.44%)
Close on Nov 13, 2026Market cap $38.36BP/E 28.5Yield –
CBRE EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
CBRE's EPS for the twelve months ending Sep 30, 2026 was $4.67, up 15.3% year over year. For fiscal 2025 it was $3.85, up 22.6% from the year before. Over ten years it grew 9.0% a year on average. The highest annual figure on record is $5.41 in fiscal 2021.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.85 | +22.6% |
| FY2024 | Dec 31, 2024 | $3.14 | -0.3% |
| FY2023 | Dec 31, 2023 | $3.15 | -26.6% |
| FY2022 | Dec 31, 2022 | $4.29 | -20.7% |
| FY2021 | Dec 31, 2021 | $5.41 | +143.7% |
| FY2020 | Dec 31, 2020 | $2.22 | -41.1% |
| FY2019 | Dec 31, 2019 | $3.77 | +21.6% |
| FY2018 | Dec 31, 2018 | $3.10 | +51.2% |
| FY2017 | Dec 31, 2017 | $2.05 | +21.3% |
| FY2016 | Dec 31, 2016 | $1.69 | +3.7% |
| FY2015 | Dec 31, 2015 | $1.63 | +12.4% |
| FY2014 | Dec 31, 2014 | $1.45 | +52.6% |
| FY2013 | Dec 31, 2013 | $0.95 | -2.1% |
| FY2012 | Dec 31, 2012 | $0.97 | +31.1% |
| FY2011 | Dec 31, 2011 | $0.74 | +17.5% |
| FY2010 | Dec 31, 2010 | $0.63 | +425.0% |
| FY2009 | Dec 31, 2009 | $0.12 | – |
| FY2008 | Dec 31, 2008 | -$4.81 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.52 | +25.6% |
| Q2 FY2026 | Jun 30, 2026 | $0.69 | -4.2% |
| Q1 FY2026 | Mar 31, 2026 | $1.07 | +98.1% |
| Q4 FY2025 | Dec 31, 2025 | $1.39 | -12.0% |
| Q3 FY2025 | Sep 30, 2025 | $1.21 | +65.8% |
| Q2 FY2025 | Jun 30, 2025 | $0.72 | +71.4% |
| Q1 FY2025 | Mar 31, 2025 | $0.54 | +31.7% |
| Q4 FY2024 | Dec 31, 2024 | $1.58 | +1.9% |
| Q3 FY2024 | Sep 30, 2024 | $0.73 | +19.7% |
| Q2 FY2024 | Jun 30, 2024 | $0.42 | -34.4% |
| Q1 FY2024 | Mar 31, 2024 | $0.41 | +10.8% |
| Q4 FY2023 | Dec 31, 2023 | $1.55 | +520.0% |
| Q3 FY2023 | Sep 30, 2023 | $0.61 | -55.8% |
| Q2 FY2023 | Jun 30, 2023 | $0.64 | -56.8% |
| Q1 FY2023 | Mar 31, 2023 | $0.37 | -68.1% |
| Q4 FY2022 | Dec 31, 2022 | $0.25 | -87.7% |
| Q3 FY2022 | Sep 30, 2022 | $1.38 | +7.8% |
| Q2 FY2022 | Jun 30, 2022 | $1.48 | +13.8% |
| Q1 FY2022 | Mar 31, 2022 | $1.16 | +48.7% |
| Q4 FY2021 | Dec 31, 2021 | $2.04 | +119.4% |
| Q3 FY2021 | Sep 30, 2021 | $1.28 | +132.7% |
| Q2 FY2021 | Jun 30, 2021 | $1.30 | +441.7% |
| Q1 FY2021 | Mar 31, 2021 | $0.78 | +52.9% |
| Q4 FY2020 | Dec 31, 2020 | $0.93 | -50.3% |
| Q3 FY2020 | Sep 30, 2020 | $0.55 | -26.7% |
| Q2 FY2020 | Jun 30, 2020 | $0.24 | -63.6% |
| Q1 FY2020 | Mar 31, 2020 | $0.51 | +6.3% |
| Q4 FY2019 | Dec 31, 2019 | $1.87 | +62.6% |
| Q3 FY2019 | Sep 30, 2019 | $0.75 | -11.8% |
| Q2 FY2019 | Jun 30, 2019 | $0.66 | -1.5% |
| Q1 FY2019 | Mar 31, 2019 | $0.48 | +9.1% |
| Q4 FY2018 | Dec 31, 2018 | $1.15 | +144.7% |
| Q3 FY2018 | Sep 30, 2018 | $0.85 | +46.6% |
| Q2 FY2018 | Jun 30, 2018 | $0.67 | +13.6% |
| Q1 FY2018 | Mar 31, 2018 | $0.44 | +10.0% |
| Q4 FY2017 | Dec 31, 2017 | $0.47 | -39.7% |
| Q3 FY2017 | Sep 30, 2017 | $0.58 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.59 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.40 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.78 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?